Kintor Pharmaceutical Limited announced that its board of directors will convene on 19 August 2026 to consider and approve the interim results for the six-month period ended 30 June 2026 and to authorize their publication.

The notice, signed by Chairman, Executive Director and Chief Executive Officer Dr. Youzhi Tong, was released in Hong Kong on 5 August 2026.

As of the announcement date, the board comprises: • Executive Directors: Dr. Youzhi Tong and Dr. Xiang Ni • Non-Executive Directors: Mr. Yunfei Chen and Ms. Geqi Wei • Independent Non-Executive Directors: Dr. Michael Min Xu, Mr. Wallace Wai Yim Yeung and Prof. Liang Tong